Cargando…

Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?

The true onset of atherosclerosis remains one of the biggest challenges for cardiologists. Is atheroma plaque development considered the earliest step of vascular aging? If so, when it starts? Before or after birth? If it starts before birth or early during childhood, it seems that Thomas Sydenham w...

Descripción completa

Detalles Bibliográficos
Autores principales: Iurciuc, Stela, Cimpean, Anca Maria, Mitu, Florin, Heredea, Rodica, Iurciuc, Mircea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574695/
https://www.ncbi.nlm.nih.gov/pubmed/28883714
http://dx.doi.org/10.2147/CIA.S141265
_version_ 1783259891126763520
author Iurciuc, Stela
Cimpean, Anca Maria
Mitu, Florin
Heredea, Rodica
Iurciuc, Mircea
author_facet Iurciuc, Stela
Cimpean, Anca Maria
Mitu, Florin
Heredea, Rodica
Iurciuc, Mircea
author_sort Iurciuc, Stela
collection PubMed
description The true onset of atherosclerosis remains one of the biggest challenges for cardiologists. Is atheroma plaque development considered the earliest step of vascular aging? If so, when it starts? Before or after birth? If it starts before birth or early during childhood, it seems that Thomas Sydenham was right: “A man is as old as his arteries.” Except disorganization of elastic fibers, less is known about the morphology of vascular aging and also about the molecular events influencing the age of arteries, arterial stiffness, and their role in the appearance of future complications. Cellular and molecular events responsible for the switch from physiologic to pathologic aging of human arteries are less known. Epigenetic, genetic, and environmental influences at the onset of early vascular aging (EVA) should specifically influence the process. This paper briefly reviews the controversial data regarding vascular aging with an emphasis on the less known facts about the morphology of EVA.
format Online
Article
Text
id pubmed-5574695
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55746952017-09-07 Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology? Iurciuc, Stela Cimpean, Anca Maria Mitu, Florin Heredea, Rodica Iurciuc, Mircea Clin Interv Aging Expert Opinion The true onset of atherosclerosis remains one of the biggest challenges for cardiologists. Is atheroma plaque development considered the earliest step of vascular aging? If so, when it starts? Before or after birth? If it starts before birth or early during childhood, it seems that Thomas Sydenham was right: “A man is as old as his arteries.” Except disorganization of elastic fibers, less is known about the morphology of vascular aging and also about the molecular events influencing the age of arteries, arterial stiffness, and their role in the appearance of future complications. Cellular and molecular events responsible for the switch from physiologic to pathologic aging of human arteries are less known. Epigenetic, genetic, and environmental influences at the onset of early vascular aging (EVA) should specifically influence the process. This paper briefly reviews the controversial data regarding vascular aging with an emphasis on the less known facts about the morphology of EVA. Dove Medical Press 2017-08-23 /pmc/articles/PMC5574695/ /pubmed/28883714 http://dx.doi.org/10.2147/CIA.S141265 Text en © 2017 Iurciuc et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Expert Opinion
Iurciuc, Stela
Cimpean, Anca Maria
Mitu, Florin
Heredea, Rodica
Iurciuc, Mircea
Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?
title Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?
title_full Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?
title_fullStr Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?
title_full_unstemmed Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?
title_short Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?
title_sort vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574695/
https://www.ncbi.nlm.nih.gov/pubmed/28883714
http://dx.doi.org/10.2147/CIA.S141265
work_keys_str_mv AT iurciucstela vascularagingandsubclinicalatherosclerosiswhysuchaneverendingandchallengingstoryincardiology
AT cimpeanancamaria vascularagingandsubclinicalatherosclerosiswhysuchaneverendingandchallengingstoryincardiology
AT mituflorin vascularagingandsubclinicalatherosclerosiswhysuchaneverendingandchallengingstoryincardiology
AT heredearodica vascularagingandsubclinicalatherosclerosiswhysuchaneverendingandchallengingstoryincardiology
AT iurciucmircea vascularagingandsubclinicalatherosclerosiswhysuchaneverendingandchallengingstoryincardiology